<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T14:45:08Z</responseDate>
  <request identifier="oai:figshare.com:article/33828556" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33828556</identifier>
        <datestamp>2026-09-16T05:30:06Z</datestamp>
        <setSpec>category_932</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_CDTD-Agent: a retrieval-augmented multi-agent digital health framework for integrated diabetes care: a single-case expert-rated pilot study.docx</dc:title>
          <dc:creator>Jieyi Zhang (5185352)</dc:creator>
          <dc:creator>Luqing Wu (24961036)</dc:creator>
          <dc:creator>Jielong Wu (17345853)</dc:creator>
          <dc:creator>Xiaoming Han (24961039)</dc:creator>
          <dc:creator>Lijin Lin (671929)</dc:creator>
          <dc:creator>Nengjiang Zhao (12357502)</dc:creator>
          <dc:creator>Zhihai Zhang (4974026)</dc:creator>
          <dc:creator>Miaona Cai (24961042)</dc:creator>
          <dc:creator>Meiqi Chen (9438816)</dc:creator>
          <dc:creator>Shuyu Yang (401091)</dc:creator>
          <dc:creator>Bo Li (112195)</dc:creator>
          <dc:subject>Health Informatics</dc:subject>
          <dc:subject>diabetes management</dc:subject>
          <dc:subject>large language models (LLMs)</dc:subject>
          <dc:subject>multi-agent system</dc:subject>
          <dc:subject>retrieval-augmented generation (RAG)</dc:subject>
          <dc:subject>traditional Chinese medicine (TCM)</dc:subject>
          <dc:description>Background&lt;p&gt;Diabetes management increasingly requires coordination across Western medicine, traditional Chinese medicine (TCM), and lifestyle-based health management. General-purpose large language models (LLMs) can generate clinical text but may lack reliable source grounding and structured cross-disciplinary reasoning.&lt;/p&gt;Methods&lt;p&gt;We developed CDTD-Agent, a retrieval-augmented multi-agent framework that combines a domain-specific knowledge base with an Extract-Retrieve-Reason workflow. The knowledge base included 12 medical textbooks, 8 clinical guidelines, and 183 expert-reviewed diabetes cases. In a blinded single-case pilot evaluation, 30 senior experts rated anonymized recommendations from CDTD-Agent, GPT-4o, DeepSeek-V3.2-Exp, Doubao, and two attending physicians across eight dimensions. Linear mixed-effects models accounted for repeated ratings within evaluators, with Holm correction across eight omnibus tests and global Benjamini-Hochberg correction across 40 focused CDTD-Agent-versus-comparator contrasts. A post hoc backbone-only ablation compared the full framework with Qwen3–235B-A22B using the same case and external prompt without retrieval or role-structured multi-agent processing.&lt;/p&gt;Results&lt;p&gt;Significant source effects were detected in all eight dimensions after Holm correction (all adjusted p &lt; 0.001). After global false discovery rate correction, CDTD-Agent received significantly higher ratings than all three general-purpose LLMs in five dimensions: safety, examination appropriateness, Western medicine treatment appropriateness, TCM treatment appropriateness, and evidence adherence. The largest differences occurred in Western medicine treatment appropriateness, where CDTD-Agent scored 4.07 ± 0.94 versus 1.37–1.60 for the general-purpose LLMs (all adjusted p &lt; 0.001). Non-parametric sensitivity analyses agreed with the mixed-effects results for 39 of 40 focused contrasts. In the post hoc ablation, the full framework outperformed the backbone-only condition in seven of eight dimensions after Holm correction; health management was not significantly different (adjusted p = 0.080).&lt;/p&gt;Conclusion&lt;p&gt;In this standardized complex T2DM case, CDTD-Agent received favorable expert ratings relative to the evaluated general-purpose LLMs in several clinically important dimensions. These findings are scenario-specific and do not establish generalizable clinical performance or isolate the effects of individual framework components. Multicase, repeated-generation, factorial-ablation, external, and prospective validation is needed before clinical deployment.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-16T05:30:06Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fdgth.2026.1923975.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_CDTD-Agent_a_retrieval-augmented_multi-agent_digital_health_framework_for_integrated_diabetes_care_a_single-case_expert-rated_pilot_study_docx/33828556</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
